Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Dose-Ranging Study to Establish the Tolerability of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia.

NCT00436683 is registered in ClinicalTrials.gov with Ineos Healthcare Limited as lead sponsor.

NCT NCT00436683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00436683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Dose-Ranging Study to Establish the Tolerability of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia.
Lead sponsor
Ineos Healthcare Limited
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2007
Completion date
April 30, 2008
Enrollment
64 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney failure